High efficacy therapies, remyelination and ground-breaking research in MS treatment - it’s been a fantastic first day at the European Committee for Treatment and Research in Multiple Sclerosis ( @ectrimsYouTube ) here in Amsterdam.
@theMSguide shares his highlights from the day, including an unexpected discovery about Dr Barry Singer…
Be the first to know the breaking news in MS ➡️ Make sure you’re subscribed and have notifications ᴏɴ ✅
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Join the conversation:
Visit our Instagram page 👉 [ Ссылка ]
Follow us on Twitter 👉 [ Ссылка ]
Like us on Facebook 👉 [ Ссылка ]
Keep up to date on LinkedIn 👉 [ Ссылка ]
Check out our website 👉 [ Ссылка ]
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
*The information in this video represents the views and opinions of the participants. The content is not intended to be a substitute for professional medical advice.
Any research discussed in this content may be subject to participant interpretation and conclusions may change as new research emerges.
Never delay seeking medical attention or disregard medical advice because of the content in any of our videos.
#MultipleSclerosis, #MS, #ECTRIMS, #Neurology
The Highlights From Day 1 at ECTRIMS 2022
Теги
MSMultiple SclerosisNeurologyNeuroscienceChronic IllnessNeuroscientistNeurologistNeurologicalNeurological DisorderBrainMRIMRI ScanLesionBrain AtrophyMS TreatmentAutoimmuneCentral Nervous SystemAutoimmune ConditionChronic illness awarenessMS warriorBrain scandiagnosisnerve damagebrain damagemobilitydisabilitydisability awarenessmobility issuesphysical therapymobility aidprogressive